Breast Cancer Cell. Credits: Wikimedia Commons

A potential treatment for an aggressive form of breast cancer has been researched by Australian researchers. Widely referred as Triple-negative breast cancer, is one of the most difficult cancers to treat.

The Australian researchers are now anticipating to have arrived at a possible treatment for this difficult-to-treat cancer. The triple-negative breast cancer largely affects young girls. It has been found that about 15% to 25% cases of breast cancer could be the cases of triple-negative breast cancer.

Many years of research by Professor Robert Baxtor and his team at Kolling Institute of Medical Research in Sydney, Australia have found some useful results that could assist in building a treatment for the cancer.

The team of Australian researchers has discovered a source protein that helps in the growth of the breast cancer. The protein does not only lead to the growth of the breast cancer but it also makes it belligerent to the treatment, thus, making it aggressive and difficult to treat.

The very knowledge about the presence of the protein helped the Australian researchers to come up with a treatment for the fatal disease. The researchers at the medical institute have combined two drugs to come up with the treatment.

The treatment so far has been effective in the lab as reported by the researchers. Although, it is in its initial stages of testing where the tests are being done on mice. It is anticipated that the trials over humans can soon be started with. The drugs that have been used to create the cure are said to be in use, already.

"Our tests have shown the drugs to be extremely effective when used together. We are now hoping to move on to further preclinical studies," says Prof. Robert Baxtor.

The prognosis for the triple-negative breast cancer is said to be not great as reported by Dr. Libby Topp of Cancer Council NSW. "The five-year survival rate is much lower than 89% for breast cancer in general," added Libby Topp.

An event on Oct. 28, 2013 will mark the Cancer Council's Pink Ribbon Day. And the funds raised during the day will be provided for cancer treatment researches and for Prof. Robert Baxtor's and his team of Australian researchers.